Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study

Dutch Myositis Network

doi:https://doi.org/10.1016/j.jaut.2023.103081

Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study

Dutch Myositis Network

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Original language	English
Article number	103081
Journal	Journal of autoimmunity
Volume	139
DOIs	https://doi.org/10.1016/j.jaut.2023.103081
Publication status	Published - 1 Sept 2023

Keywords

COVID-19
Myositis
Myositis specific antibodies

Access to Document

https://doi.org/10.1016/j.jaut.2023.103081

Cite this

@article{2beaca0dfd6745569be160e75b68c95e,

title = "Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study",

keywords = "COVID-19, Myositis, Myositis specific antibodies",

author = "Kamperman, {Renske G.} and {van Leeuwen}, {Ester M. M.} and Myrthe Willems and {van der Kooi}, {Anneke J.} and Gelderman, {Kyra A.} and Hamann, {D. rte} and {van Lochem}, {Ellen G.} and Bob Meek and {van der Molen}, {Renate G.} and Platteel, {Anouk C. M.} and Otten, {Henny G.} and {Dutch Myositis Network} and Schreurs, {Marco W. J.} and Joost Raaphorst",

note = "Funding Information: Several authors of this publication are members of the Netherlands Neuro-muscular Centre (NL-NMD) and the European Reference Network for rare neuromuscular diseases ERN-EURO-NMD.",

year = "2023",

month = sep,

day = "1",

doi = "https://doi.org/10.1016/j.jaut.2023.103081",

language = "English",

volume = "139",

journal = "Journal of autoimmunity",

issn = "0896-8411",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study

AU - Kamperman, Renske G.

AU - van Leeuwen, Ester M. M.

AU - Willems, Myrthe

AU - van der Kooi, Anneke J.

AU - Gelderman, Kyra A.

AU - Hamann, D. rte

AU - van Lochem, Ellen G.

AU - Meek, Bob

AU - van der Molen, Renate G.

AU - Platteel, Anouk C. M.

AU - Otten, Henny G.

AU - Dutch Myositis Network

AU - Schreurs, Marco W. J.

AU - Raaphorst, Joost

N1 - Funding Information: Several authors of this publication are members of the Netherlands Neuro-muscular Centre (NL-NMD) and the European Reference Network for rare neuromuscular diseases ERN-EURO-NMD.

PY - 2023/9/1

Y1 - 2023/9/1

KW - COVID-19

KW - Myositis

KW - Myositis specific antibodies

UR - http://www.scopus.com/inward/record.url?scp=85165237146&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.jaut.2023.103081

DO - https://doi.org/10.1016/j.jaut.2023.103081

M3 - Article

C2 - 37393780

SN - 0896-8411

VL - 139

JO - Journal of autoimmunity

JF - Journal of autoimmunity

M1 - 103081

ER -

Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study

Keywords

Access to Document

Other files and links

Cite this